Caleb Scheckel
Impact in
-
- Meta-analysis and systematic reviews
-
- Acute Myeloid Leukemia Research
Papers in
-
- Economic and Financial Impacts of Cancer 4
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Acute Lymphoblastic Leukemia research 2
- Clinical practice guidelines implementation 2
- Co-authors
- Matt Vassar (5 shared papers)Ronald S. Go (8 shared papers)Mousumi Som (1 shared paper)Cole Wayant (1 shared paper)Thai H. Ho (1 shared paper)Jason Joe Baker (1 shared paper)Talal Hilal (1 shared paper)Andrew Ross (1 shared paper)
- Journals
- PLoS ONE (3 papers)Blood (2 papers)Journal of Clinical Oncology (2 papers)Mayo Clinic Proceedings (2 papers)Hematology/Oncology Clinics of North America (1 paper)
- Partner nations
- United States
In The Last Decade
Caleb Scheckel
22 papers receiving 236 citations
Peers
Comparison fields: 5 of 70
- Statistics, Probability and Uncertainty 54
- Hematology 22
- Physiology 36
- Complementary and Manual Therapy 2
- Surgery 39
Countries citing papers authored by Caleb Scheckel
This map shows the geographic impact of Caleb Scheckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caleb Scheckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caleb Scheckel more than expected).
Fields of papers citing papers by Caleb Scheckel
This network shows the impact of papers produced by Caleb Scheckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caleb Scheckel. The network helps show where Caleb Scheckel may publish in the future.
Co-authors
The 25 scholars most cited alongside Caleb Scheckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 40 | |
| 2 | 2020 | 26 | |
| 3 | 2017 | 26 | |
| 4 | 2022 | 24 | |
| 5 | 2017 | 23 | |
| 6 | 2019 | 19 | |
| 7 | 2022 | 13 | |
| 8 | 2020 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 8 | |
| 11 | 2016 | 8 | |
| 12 | 2016 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2018 | 4 | |
| 15 | 2020 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2018 | 3 | |
| 20 | 2020 | 1 |
About Caleb Scheckel
Caleb Scheckel is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Epidemiology, Hematology and Physiology, having authored 25 papers that have together received 244 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (4 papers), Meta-analysis and systematic reviews (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Histiocytic Disorders and Treatments (2 papers), Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Clinical practice guidelines implementation (2 papers) and Therapeutic Uses of Natural Elements (1 paper). The work is most often cited by research in Statistics, Probability and Uncertainty (54 citations), Hematology (22 citations), Physiology (36 citations), Complementary and Manual Therapy (2 citations) and Surgery (39 citations). Caleb Scheckel has collaborated with scholars based in United States. Frequent co-authors include Matt Vassar, Ronald S. Go, Mousumi Som, Cole Wayant, Thai H. Ho, Jason Joe Baker, Talal Hilal, Andrew Ross, Jared Scott and Richard Butterfield. Their work appears in journals such as PLoS ONE, Blood, Journal of Clinical Oncology, Mayo Clinic Proceedings and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.